Scopus BioPharma News

Scopus BioPharma | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Jan 19 13:00

Scopus BioPharma | 8-K: Current report

Aug 19, 2023 05:16

Scopus BioPharma | 8-K: Current report

Aug 12, 2023 05:01

Scopus BioPharma | DEF 14A: Definitive information statements

Jul 22, 2023 05:00

Scopus BioPharma | NT 10-K: Others

Apr 1, 2023 05:00

Scopus BioPharma | 8-K: Current report

Dec 16, 2022 19:05

Scopus BioPharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Dec 3, 2022 06:16

Scopus BioPharma | 8-K: Current report

Dec 3, 2022 06:15

Scopus BioPharma | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Nov 16, 2022 06:15

Scopus BioPharma | 8-K: Current report

Oct 21, 2022 05:15

Scopus BioPharma | 8-K: Current report

Oct 19, 2022 21:15

Scopus BioPharma | 8-K: Current report

Oct 8, 2022 05:16

Scopus BioPharma | 8-K: Current report

Sep 17, 2022 05:15

Scopus BioPharma | 8-K: Current report

Sep 3, 2022 05:15

Scopus BioPharma | 8-K: Current report

Jul 16, 2022 05:15

Scopus BioPharma | 8-K: Current report

May 28, 2022 05:15

Scopus BioPharma | 8-K: Current report

May 21, 2022 05:15

Scopus BioPharma | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 14, 2022 05:17

Scopus BioPharma | 8-K: Current report

May 14, 2022 05:16

Scopus BioPharma | 8-K: Current report

May 5, 2022 05:16